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products of oncogenes or tumor repression genes 
including c-fos , c-myc , p53  and Rb  and its alteration of 
distributive area in the cells treated by HMBA.
CONCLUSION: These data confirm that PHB is a 
nuclear matrix protein, which is located in the nuclear 
matrix, and the distribution and expression of PHB and 
its relation with associated genes may play signifi cant 
roles during the differentiation of SMMC-7721 cells.
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INTRODUCTION
Prohibitin (PHB) is a tumor suppressor protein that is 
expressed in a variety of  cell lines. It is not only localized 
to the inner membrane of  mitochondria, where it 
acts as a chaperone protein, but is also present in the 
nucleus where it negatively regulates transcription. PHB 
plays important roles in the regulation of  cell growth, 
proliferation, differentiation, aging and apoptosis. It 
is also involved in the genesis of  tumor and some 
degenerative diseases[1-3]. In cell differentiation, some 
studies have found that the expression level of  PHB 
was very low in rapidly proliferating cells, whereas it was 
much higher in cells undergoing differentiation. This 
indicates that PHB may promote cell differentiation 
and suppress cell proliferation[4]. Heretofore, over-
expression of  PHB has been found in various tumor 
cells. This seems to be conflictive with its tumor 
suppressive function. So far, the mechanism of  its 
subcellular localization, nuclear transportation and 
regulation of  cell proliferation and differentiation are 
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Abstract
AIM: To explore the existence and distribution of 
prohibitin (PHB) in nuclear matrix and its co-localization 
with products of some related genes during the 
differentiation of human hepatocarcinoma SMMC-7721 
cells.
METHODS: The nuclear matrix of the SMMC-7721 cells 
cultured with or without 5 × 10-3 mmol/L hexamethylene 
bisacetamide (HMBA) was selectively extracted. 
Western blot was used to analyze the expression of 
PHB in nuclear matrix; immunofl uorescence microscope 
observation was used to analyze the distribution of PHB 
in cell. LCSM was used to observe the co-localization of 
PHB with products of oncogenes and tumor suppressor 
genes.
RESULTS: Western blot analysis showed that PHB 
existed in the composition of nuclear matrix proteins 
and was down-regulated by HMBA treatment. 
Immunofluorescence observation revealed that PHB 
existed in the nuclear matrix, and its distribution 
regions and expression levels were altered after 
HMBA treatment. Laser scanning confocal microscopy 
revealed the co-localization between PHB and the 
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not well understood. Our previous studies revealed that 
PHB existed in nuclear matrix extractions of  human 
adenocarcinoma MGc80-3 cells, and its expression 
level was altered during the differentiation induced by 
hexamethylene bisacetamide (HMBA)[5]. Furthermore, 
in the differentiation of  human osteosarcoma MG-63 
cells, we observed similar results[6]. This implies that 
PHB might be a common differentially expressed 
nuclear matrix protein in some tumor cells. In this 
study, we further studied the existence, localization, 
expression alteration of  PHB in the nuclear matrix and 
the relationship between PHB and related products 
of  oncogenes during the differentiation of  human 
hepatocarcinoma SMMC-7721 cells induced by HMBA. 
This study provides scientifi c evidence for the function 
of  PHB during cell differentiation and understanding 
of  the mechanism of  development of  cancer and its 
reversion.
MATERIALS AND METHODS
Materials
Human hepatocarcinoma SMMC-7721 cells were 
obtained from China Center for Type Culture Collection 
(Wuhan University). RPMI-1640 was from Gibco Co., 
newborn calf  serum was from Hangzhou Sijiqing 
Biological Engineering Materials Co., Ltd. HMBA was 
from Sigma Co. The antibodies used are listed in Table 1.
Cell culture and inducement
Human hepatocarcinoma SMMC-7721 cells were cultured 
at 37? in RPMI-1640 medium (pH 7.2) supplemented 
with 15% newborn calf  serum, 100 U/mL penicillin, 
100 U/mL streptomycin and 50 µg/mL kanamycin. 
Cells were passaged in log phase. Twenty-four hours after 
passaging the cells the experimental group was treated 
with culture media containing 5 mmol/L HMBA. Fresh 
culture media was added to the cells every 48-72 h. Cells 
were harvested at subconfl uency.
Cell selective extraction and sample preparation for 
light microscope
The cells were selectively extracted as described in our 
previous article[7]. The nuclear matrix-intermediate 
filament (NM-IF) samples on the cover slip strips after 
the selective extraction were prefi xed in 2% glutaraldehyde 
at 4? for 30 min, and rinsed in phosphate-buffered saline 
(PBS), pH 7.4. The samples were then stained with 0.2% 
Coomassie brilliant blue for 20 min, washed in distilled 
water, air dried, clarifi ed by xylene, enveloped in the resin, 
and observed using an Olympus BH-2 microscope.
Purifi cation of nuclear matrix proteins
Nuclear matrix proteins of  SMMC-7721 cells were 
pur i f ied by us ing a rout ine method with a few 
improvements[8]. The SMMC-7721 cells were washed 
with PBS and extracted with cytoskeleton buffer 
(CSK100) (10 mmol/L PIPES pH 6.8, 300 mmol/L 
sucrose, 100 mmol/L NaCl, 4 mmol/L CaCl2, 1.0 
mmol/L PMSF, 0.5% Triton X-100) at 0? for 10 min, 
and subjected to centrifugation for 5 min at 400 g. 
The pellet was washed twice with CSK50 (10 mmol/L 
PIPES pH 6.8, 300 mmol/L sucrose, 50 mmol/L NaCl, 
4 mmol/L CaCl2, 1.0 mmol/L PMSF, 0.5% Triton 
X-100) and digested for 30 min at 25? in the same 
buffer containing 300 U/mL DNase I. One mole per 
liter ammonium sulfate was added dropwise to a final 
concentration of  0.25 mmol/L. After incubation for 
15 min, the nuclear matrix proteins were pelleted by 
centrifugation at 1000 r/min for 5 min, and washed once 
with the CSK50 buffer, then stored at -80?.
Western blot of PHB
The nuclear matrix proteins were separated by SDS-
PAGE and then transferred onto PVDF membranes. 
Nonspecifi c reactivity was blocked by incubation at room 
temperature for 1.5 h in 5% BSA buffer. The membrane 
was then incubated with PHB (1:2000) primary 
antibody at room temperature for 2 h. After washing, a 
horseradish peroxidase tagged secondary antibody was 
used to detect the primary antibody. Reactive protein 
was detected by the enhanced chemiluminescence 
(ECL) detection system (Pierce). As a negative control, 
the primary antibody was replaced by 5% BSA buffer. 
β-actin was also detected as an internal control.
Sample preparation for fl uorescence microscopy
The NM-IF samples on the cover slip were prefixed 
in 4% paraformaldehyde at 4? for 10 min, rinsed in 
the TPBS (contain 0.5% Triton X-100) twice, 5 min 
each, blocked by 5% BSA at room temperature for 1 h, 
incubated with mouse anti-PHB monoclonal antibody 
(1:300) at room temperature for 30 min, and 4? 
overnight, then washed 3 times with TPBS. Then, the 
cells were incubated with goat anti-mouse secondary 
antibody labeled with f luorescence dye TRITC, 
washed with water and dried by airing. Afterwards, 
90% glycerol/PBS was applied and the cells observed 
using fl uorescence microscopy. The entire process after 
incubation with secondary antibody was performed in 
the dark. The primary antibody was replaced by 5% BSA 
buffer as a negative control.
Sample preparation for LSCM
Cells on the cover slips were rinsed in PBS, submerged 
in TBS (including 0.5% Triton X-100) for 30 min. 
After being washed with PBS, the cells were fixed in 
4% paraformaldehyde for 10 min, blocked with 5% 
Table 1  Antibodies used in the study
Antibodies Source Antibodies Source
Mouse anti-human PHB NeoMarkers 
Co.
Goat anti-mouse 
IgG/HRP
Boster Co.
Goat anti-rabbit IgG-FITC KPL Co. Goat anti-rabbit 
IgG/HRP
Boster Co.
Goat anti-mouse 
IgG-TRITC
KPL Co. Rabbit anti-p53 Boster Co.
Rabbit anti-human β-actin Boster Co. Rabbit anti-pRb Boster Co.
Rabbit anti-c-Fos Boster Co. Rabbit anti-c-Myc Boster Co.
BSA at room temperature for 1 h, and then incubated 
with dual primary antibodies at room temperature for 
30 min and then 4? overnight. The dual primary 
antibody sets comprised of  PHB (1:1000)/c-Fos (1:200), 
PHB (1:1000)/c-Myc (1:200), PHB (1:1000)/p53 (1:200), 
PHB (1:1000)/pRb (1:200). After being washed with 
TTBS, the cells were incubated with different secondary 
antibody sets (goat anti rabbit or goat anti mouse) which 
were labeled with FITC and TRITC, respectively, at 
room temperature for 30 min and then 4? overnight, 
washed with TPBS, enveloped with 90% glycerol/PBS 
after drying and then observed under LSCM (TCS- SP2 
MP).
RESULTS
Detection of PHB in nuclear matrix by Western blot
Western blot results showed the dominant PHB band 
located at 32 kDa (PHB) and β-actin positioned at 42 
kDa. The immunoband of  PHB in the nuclear matrix 
of  SMMC-7721 cells was obviously fuscous, while it was 
light and thin in HMBA-treated cells. The expression 
level of  hnRNP A2/B1 was signifi cantly decreased. The 
expression level of  β-actin, which was referred to as 
endogenous control, had no obvious changes (Figure 1).
Localization and expression of PHB in the NM-IF system 
of SMMC-7721 cells
Light microscopy observation revealed that the 
intermediate fi laments in SMMC-7721 cells were sparse 
and arranged irregularly. In HMBA-treated MG-63 cells, 
the whole framework became more outspread, and 
the NM-IF system showed characteristics of  uniform 
distribution. The intermediate filaments, which were 
uniformly stained, spread from the region around the 
nucleus to the cellular edge and formed a well-distributed 
and regular network throughout the cytoplasmic region. 
The nuclear matrix fi laments were abundant and evenly 
distributed (Figure 2A and B).
The observation of  immunofl uorescence revealed the 
localization and expression of  PHB. PHB was labeled 
with TRITC (red). The results showed PHB existed in the 
whole cell, but was weak in nuclei where it was scattered 
as little particles. It was relatively strong in regions near 
the nuclear membrane. The distribution of  PHB was 
uniform in the cytoplasmic region (Figure 2C). After 
treatment with HMBA, the distribution and expression of  
PHB in the NM-IF system was signifi cantly altered. The 
holistic intensity of  the fluorescence in nuclear matrix 
and nuclear lamina region dropped dramatically, while the 
fl uorescence in the cytoplasmic region of  HMBA-treated 
cells strengthened. It displayed a tendency of  transferring 
from NM to lamina and cytoplasm of  PHB (Figure 2D).
Co-localization study of PHB with products of several 
predominant oncogenes and tumor suppressor genes
The localization of  PHB and the opposite proteins 
including c-Fos, c-Myc, p53 and pRb were observed 
by LSCM. PHB was labeled with TRITC (red), other 
proteins were labeled with FITC (green). The co-
localization fl uorescence was yellow or orange when two 
different colors of  fl uorescence overlapped (Figure 3).
In SMMC-7721 cells, PHB mainly distributed in the 
nucleus, nuclear membrane, cytoplasm and the edge 
region of  cells. In karyoplasm, the fluorescence was 
relatively weak and scattered unevenly. In SMMC-7721 
cells treated with HMBA, PHB expression became 
decreased or even disappeared in the nuclear regions and 
was enhanced and scattered broadly in the cytoplasm.
Co-localization of PHB with c-Fos in SMMC-7721 cells
In SMMC-7721 cells, c-Fos was distributed mainly in the 
nucleolus region. The yellow overlapped fluorescence 
indicated co-localization between PHB and c-Fos 
existed mainly in the nucleolus region. In SMMC-7721 
cells treated with HMBA, the holistic intensity of  PHB 
and c-Fos fluorescence all weakened. The overlapped 
fl uorescence indicated that the co-localization between 
PHB and c-Fos in the nucleolus weakened, but the co-
localized fl uorescence in karyotheca and cytoplasm was 
enhanced. It seemed that the co-localized region of  
both proteins transferred from the nucleolus region to 
karyotheca and cytoplasm (Figure 3A-F).
Co-localization of PHB with c-Myc in SMMC-7721 cells
In SMMC-7721 cells, the highly-expressed c-Myc 
distributed mainly in the nucleolus and its peripheral 
regions. The overlapped fluorescence indicated they 
were co-localized in karyoplasms and karyotheca. In 
SMMC-7721 cells induced by HMBA, c-Myc dispersed 
in the whole cell, and its expression decreased. The 
overlapped fluorescence of  PHB and c-Myc showed 
that the co-localization of  two proteins strengthened 
in the karyotheca region, and clustered co-localization 
fluorescence could be seen in some special places. 
It indicated the tendency of  transportation from 
karyoplasm to the nearby nuclear membrane (Figure 
3G-L).
Co-localization of PHB with p53 in SMMC-7721 cells
Due to the short half-life of  wild-p53 in tumor cells 
(6 min), the p53 detected in this article was mostly its 
mutant counterpart namely mtp53. In SMMC-7721 
cells, the highly-expressed mtp53 concentrated mainly 
119 kDa
79 kDa
46 kDa
31 kDa
24 kDa
19 kDa
 1       2     3
? β-actin (42 kDa)
? Prohibitin (32 kDa)
Figure 1  Western 
blot of PHB in nuclear 
matrix of SMMC-7721 
cell. Lane 1: Marker; 
Lane 2: SMMC-7721 
cells; Lane 3: HMBA-
treated cells.
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in the nucleolus and evenly distributed in other regions 
of  the nucleus. The overlapped fluorescence indicated 
the co-localization distributed mainly in the region of  
karyoplasm and cytoplasm. In SMMC-7721 cells induced 
by HMBA, mtP53 decreased and its distribution was 
much more dispersive than that of  untreated cells. The 
overlapped fluorescence showed the co-localization 
region of  two proteins existed in the cytoplasm and 
lamina regions, and the co-localization fluorescence 
weakened remarkably after treatment (Figure 3M-R).
 
Co-localization of PHB with pRb in SMMC-7721 cells
In SMMC-7721 cells, Rb expression in the nucleolus 
was stronger than in other regions where it was relatively 
weak and distributed evenly. The overlapped fl uorescence 
indicated they were co-localized in most regions of  the 
nuclear membrane and cytoplasm. After treatment with 
HMBA, Rb increased remarkably and localized mainly at 
the nuclear membrane and nucleus regions after HMBA 
treatment. The overlapped fl uorescence indicated the co-
localization region of  two proteins existed mainly in the 
nuclear membrane. It also showed their co-localization 
had a tendency of  transferring from the cytoplasm to 
the nuclear membrane during the differentiation of  
SMMC-7721 cells (Figure 3S-X).
DISCUSSION
Changes of the expression and localization of PHB in 
the nuclear matrix
PHB is an important tumor suppressor protein. It 
not only mediates signaling of  cell proliferation by 
acting as a membrane receptor, but is also involved 
in the maintenance of  stabil i ty and function of  
mitochondria. Previous studies have shown that PHB 
was mainly present in the mitochondria, and could 
be found in other subcellular organelles rarely[9,10]. So 
far, the localization of  PHB in the nuclear matrix has 
not been reported. In this study, Western blot analysis 
confirmed that PHB was one of  the components of  
the nuclear matrix and its expression in the nuclear 
matrix was down-regulated remarkably after treatment 
with HMBA. Immunofl uorescence microscopy revealed 
that PHB was distributed mainly in the regions of  the 
nuclear membrane and cytoplasm of  SMMC-7721 
cells. These results indicate that PHB exists not only 
in the cytoplasm, but also in the nuclear matrix of  
SMMC-7721 cells. Therefore, our laboratory, for the fi rst 
time, has discovered the subcellular location of  PHB in 
the nuclear matrix and showed it was a nuclear matrix 
protein.
PHB has great relevance to the development of  
cancer. Recent studies have shown that expression of  
PHB was abnormal in a variety of  tumor cell lines[11-14]. 
In this study, using Western blot analysis, we found PHB 
is expressed highly in the nuclear matrix of  SMMC-7721 
cells, but in cells treated with HMBA, its expression was 
down-regulated. Immunofl uorescent microscopy showed 
that the distribution of  PHB in the nuclear matrix of  
SMMC-7721 cells was altered after HMBA treatment. 
PHB was mainly distr ibuted in the karyoplasms 
and cytoplasm region, while in the HMBA-treated 
cells, PHB localized to the nuclear membrane and 
cytoplasm. PHB might have undergone translocation 
from nucleus to cytoplasm. Over expression of  PHB 
has been reported in many kinds of  tumor cells[15,16]. 
Our previous studies on the nuclear matrix proteins 
Figure 2  A: LM observation 
o f  N M - I F  s y s t e m  i n 
SMMC-7721 cells, coomassie 
brilliant blue staining, bar = 
10 µm; B: LM observation of 
NM-IF system in SMMC-7721 
cells after HMBA treatment, 
Coomassie br i l l iant  b lue 
staining, bar = 10 µm; C: 
Immunofl uorescence staining 
of PHB in the NMIF system of 
SMMC-7721 cells, bar = 10 
µm; D: Immunofluorescence 
staining of PHB in the nuclear 
matrix-intermediate filament 
system of SMMC-7721 cells 
after HMBA treatment, bar = 
10 µm.
A B
C D
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of  human adenocarcinoma MGc80-3 and human 
osteosarcoma MG-63 cells showed that PHB existed 
as a component of  the nuclear matrix, and expression 
of  PHB was down-regulated during differentiation. 
Therefore, our results further affirmed the alterations 
of  PHB expression, and confi rmed the involvement of  
Figure 3  LSCM observation of the co-localization of PHB, bar = 10 µm. A-F: With c-Fos in SMMC-7721 cells; G-L: With c-Myc in SMMC-7721 cells; M-R: With mtp53 
in SMMC-7721 cells; S-X: With pRb in SMMC-7721 cells.
Overlay Overlay
      SMMC-7721            HMBA       SMMC-7721           HMBA
A D M P
B E N Q
C F O R
G J S V
H K T W
I L U X
PHB
c-Fos
Overlay
PHB
c-Myc
PHB
Mtp53
Overlay
PHB
pRb
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PHB in the regulation of  tumor cell proliferation and 
differentiation.
Co-localization of PHB with products of related genes 
and its alteration during differentiation of SMMC-7721 
cells
The regulation of  PHB in cell proliferation, senescence, 
apoptosis and differentiation involves complicated 
molecular mechanisms, including interaction between 
PHB and associated regulators in signaling and cell 
cycle, the subcellular localization of  PHB in the cell, 
the phosphorylation level of  PHB, and the connection 
between PHB and related oncogenes[17-19]. In this study, 
the results of  laser scanning confocal microscopy 
revealed that there was a co-localizational relationship 
between PHB and the products of  c-fos, c-myc, p53 and Rb 
genes in SMMC-7721 cells, and the co-localization areas 
changed after HMBA treatment.
c-fos and c-myc are oncogenes whose expressions are up-
regulated frequently in hepatocellular carcinomas (HCC). 
Our research indicated PHB colocalized with c-Fos, 
c-Myc in the nuclear region of  SMMC-7721 cells. When 
SMMC-7721 cells were induced into differentiation, the 
co-localization relationship of  PHB with c-Fos and c-Myc 
strengthened in the regions of  lamina and karyotheca, 
but weakened in the karyoplasms. Other studies showed 
that PHB was a downstream target gene of c-myc and 
c-myc could bind to the promoter region of  the PHB 
gene[20]. This indicated the close relation between PHB 
and c-Myc. The direct interaction of  PHB and c-Fos 
has not yet been reported. Our research showed the 
co-localization between PHB and c-Myc, c-Fos in the 
region of  the nucleus, and its alteration in SMMC-7721 
cells after treatment with HMBA. It suggested that PHB 
might interact directly with the products of  c-myc and 
c-fos genes. Our study discovered that PHB and p53 were 
co-localized at the nuclear membrane and karyoplasms 
region. The co-localization fluorescence transferred 
from nucleus to cytoplasm after HMBA treatment. This 
suggested that PHB might have direct connection with 
p53. Recently, some studies showed that PHB and p53 
could cooperate with each other and participated in 
regulating downstream gene expression. Some studies 
found co-localization between PHB, p53 and E2F1 in the 
nucleus of  breast cancer cells, and demonstrated PHB 
could activate transcription mediated by p53 and enhance 
binding of  p53 with the promoter. It is also reported 
that p53-PHB complex translocated from nucleus to 
cytoplasm after stimulation by the signal of  apoptosis[21-23]. 
Our results were consistent with former studies. It implies 
that PHB can directly interact with p53 and participate 
in the regulation of  transcription mediated by p53. The 
co-transferring of  p53 and PHB may be one of  the 
mechanisms that mediate regulation of  cell proliferation 
and differentiation. The studies about Rb and PHB 
showed that PHB could cooperate with products of  
Rb, a dominant tumor suppressor gene which regulates 
transcriptional activity of  E2F. PHB could also form a 
triad with Rb and E2F in the nucleus, suppress activity 
of  E2F, and thereby inhibit cell proliferation[24,25]. The 
results of  this study revealed that the co-localizational 
fluorescence in the region of  the nuclear lamina was 
enhanced after HMBA treatment. It is obvious that the 
alteration is correlative with the state of  proliferation 
and differentiation of  SMMC-7721 cells. Nuclear lamina 
is the active site of  DNA replication and transcription. 
Because of  these, the alteration of  PHB transferring and 
its enhanced combination with Rb in the lamina might 
repress the activity of  E2F which promotes transcription 
of  its downstream genes.
Taken together, these findings suggest that the 
subcellular localization and altered expression of  PHB 
may have a potential role in the differentiation and 
phenotype reversion of  SMMC-7721 cells by cooperating 
with products of  oncogenes or tumor suppressor genes. 
Further investigation of  the function of  PHB in the 
nuclear matrix will help to clarify the mechanism of  cell 
differentiation, cell cancer development and its reversion.
 COMMENTS
Background
Previous studies showed that prohibitin (PHB) played important roles in the 
regulation of cell growth, proliferation, differentiation and tumorigenesis. 
However, the existence and expression of PHB in the nuclear matrix of tumor 
cells have not been well illustrated, and the functions of PHB in the induced 
differentiation of human hepatocarcinoma SMMC-7721 cells have also not been 
investigated in detail.
Research frontiers
To identify differentially expressed nuclear matrix proteins and analyze their 
function in cancer cell differentiation is one of the most interesting hotspots in 
current studies of nuclear matrix.
Innovations and breakthroughs
The authors revealed for the fi rst time that PHB was a nuclear matrix protein 
in SMMC-7721 cells, and the distribution/expression of PHB and its relation 
with associated genes played a significant roles during the differentiation of 
SMMC-7721 cells.
Applications
PHB can be used as a potential target in both diagnosis and treatment of 
tumors.
Terminology
Nuclear matrix is the residual protein structure that remains after the nuclei are 
depleted of the nuclear membranes, histones, soluble nuclear proteins and 
nucleic acids. The structures that remain in matrix preparations are the nuclear 
lamina, the residual nucleolus and the fi brillogranular network.
Peer review
The study is about the expression and distribution of proteins. Scientifi c content 
is interesting as several protein complexes are involved in cellular processes 
and identifi cation of a role for PHB in carcinogenesis by association with other 
oncogenes is intriguing.
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